🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Maria Diab

Henry Ford Health System

ORCID: 0000-0002-4809-9535

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer”.

Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007235

N/A

1.0DataRank · unranked

45 citations

Batoul Farran, Jeffrey M. Switchenko, Manali Rupji, Sandra Kang, Lana Khalil +9 more

Predictive and Prognostic Effects of Primary Tumor Size on Colorectal Cancer Survival

Frontiers in Oncology(2021)10.3389/fonc.2021.728076

N/A

0DataRank · unranked

39 citations

Wei Zhou, Renjian Jiang, Katerina Zakka, Zhonglu Huang, Chimuanya Okoli +6 more

High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer

Frontiers in Oncology(2021)10.3389/fonc.2021.755113

N/A

0DataRank · unranked

15 citations

Renjian Jiang, Philip A. Philip, Maria Diab, Madhusmita Behera, Christina Wu +7 more

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer

The Oncologist(2022)10.1093/oncolo/oyac082

N/A

0DataRank · unranked

9 citations

Xingyu Gao, Jeffrey M. Switchenko, Olatunji B. Alese, Mehmet Akce, Christina Wu +4 more

Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-6

N/A

0DataRank · unranked

8 citations

Betül Gök Yavuz, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Zishuo Ian Hu +13 more

XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial

OncoImmunology(2025)10.1080/2162402x.2025.2475620

N/A

0DataRank · unranked

13 citations

Olatunji B. Alese, Natalie K. Horvat, Emily R. Greene, Olumide B. Gbolahan, Kathleen Coleman +11 more

High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma

Cancer Research(2025)10.1158/0008-5472.can-25-1697

N/A

0DataRank · unranked

4 citations

Natalie K. Horvat, Deon B. Doxie, Vaunita C Parihar, Jayden Kim, Cameron J. Herting +15 more

High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Signatures Between Primary and Metastatic Pancreatic Ductal Adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.18.649381

N/A

0DataRank · unranked

0 citations

Natalie K. Horvat, Deon B. Doxie, Vaunita Parihar, Jayden Kim, Cameron J. Herting +15 more

Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth

Cancers(2020)10.3390/cancers12030750

N/A

0DataRank · unranked

38 citations

Gabriel Mpilla, Rachel Sexton, Srikant Viswanadha, Kumar V. Penmetsa, Amro Aboukameel +10 more

A phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling

Cancer Letters(2025)10.1016/j.canlet.2025.218233

N/A

0DataRank · unranked

0 citations

Maria Diab, Maggie J. Phillips, Ashley A. McCook‐Veal, Erin E. Grundy, Olatunji B. Alese +12 more